Skip to main content
editorial
. 2020 Dec 6;8(23):5835–5843. doi: 10.12998/wjcc.v8.i23.5835

Figure 1.

Figure 1

Therapeutic strategy based on viral kinetics and immunopathogenesis during the course of coronavirus disease 2019. sIL-6 receptor: Soluble form of interleukin-6 receptor; NK cells: Natural killer cells; TNF-α: Tumor necrosis factor-alpha.